Tags

Type your tag names separated by a space and hit enter

Immunisation against hepatitis A, hepatitis B and typhoid fever via combined vaccination: rationale, immunogenicity and reactogenicity.
BioDrugs. 2003; 17 Suppl 1:7-10.B

Authors+Show Affiliations

Abteilung für Infektions- und Tropenmedizin, Klinikum Innenstadt der Ludwigs-Maximilians-Universität München, Munich, Germany. stephan.proell@epost.de

Pub Type(s)

Clinical Trial
Comparative Study
Journal Article
Randomized Controlled Trial

Language

eng

PubMed ID

12785871

Citation

Proell, Stephan. "Immunisation Against Hepatitis A, Hepatitis B and Typhoid Fever Via Combined Vaccination: Rationale, Immunogenicity and Reactogenicity." BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, vol. 17 Suppl 1, 2003, pp. 7-10.
Proell S. Immunisation against hepatitis A, hepatitis B and typhoid fever via combined vaccination: rationale, immunogenicity and reactogenicity. BioDrugs. 2003;17 Suppl 1:7-10.
Proell, S. (2003). Immunisation against hepatitis A, hepatitis B and typhoid fever via combined vaccination: rationale, immunogenicity and reactogenicity. BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, 17 Suppl 1, 7-10.
Proell S. Immunisation Against Hepatitis A, Hepatitis B and Typhoid Fever Via Combined Vaccination: Rationale, Immunogenicity and Reactogenicity. BioDrugs. 2003;17 Suppl 1:7-10. PubMed PMID: 12785871.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Immunisation against hepatitis A, hepatitis B and typhoid fever via combined vaccination: rationale, immunogenicity and reactogenicity. A1 - Proell,Stephan, PY - 2003/6/6/pubmed PY - 2004/3/3/medline PY - 2003/6/6/entrez SP - 7 EP - 10 JF - BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy JO - BioDrugs VL - 17 Suppl 1 SN - 1173-8804 UR - https://www.unboundmedicine.com/medline/citation/12785871/Immunisation_against_hepatitis_A_hepatitis_B_and_typhoid_fever_via_combined_vaccination:_rationale_immunogenicity_and_reactogenicity_ L2 - https://dx.doi.org/10.2165/00063030-200317001-00002 DB - PRIME DP - Unbound Medicine ER -